Trends and determinants of active school travel among Australian secondary school students: national cross-sectional data from 2009 to 2018.

Objective: To examine active school travel trends and predictors among Australian secondary school students (aged 12-17) between 2009 and 2018.

Methods: Three cross-sectional surveys (2009-10: N=13,790; 2012-13: N=10,309; and 2018: N=9,102) using a web-based self-report questionnaire. Logistic regression was used to identify differences in active travel (to and/or from school every weekday) between survey years and predictors.

A pilot model of patient education and counselling for drug-resistant tuberculosis in Daru, Papua New Guinea.

Education and counselling for people with drug-resistant tuberculosis (DR-TB) is recommended by the World Health Organization, given the arduous treatment journey. A model of education and counselling involving counsellors and peer counsellors, standard sessions and novel education tools was piloted in the high DR-TB burden context of Daru, Papua New Guinea. The pilot contributed to high retention in care, highlighting the need for investment in scalable models.

Which attributes within target product profiles for tuberculosis diagnostics are the most important to focus on?

Setting: New diagnostic tools for tuberculosis (TB) are urgently needed. To guide investment decisions, sufficient information regarding which test attributes are the most important for users and decision makers interested in introducing TB diagnostics should be made available.

Objective: To rank test attributes in a target product profile (TPP) in order of importance for a sputum smear replacement test for TB.

New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients.

Type 2 diabetes mellitus (DM), which is epidemic in low- and middle-income countries (LMICs), may threaten gains made in tuberculosis (TB) control, as DM is both a major risk factor for developing active TB and it can lead to adverse TB treatment outcomes. Despite World Health Organization guidance that all TB patients should be screened for DM, most facilities in LMICs that manage TB patients do not currently perform screening for DM, due in part to the cost and complexity involved. DM screening is further complicated by the presentation of transient hyperglycemia in many TB patients, as well as differences in diabetes risk factors (e.